[1]LI Chun-Pu, WANG Jing, LIU Yan,et al.Inhibition of RPMI 8226 myeloma cell xenografted tumor angiogenesis by down regulation of Notch1[J].J Int Oncol,2015,661.
[2]Galletti S, Colombo M, Ravaioli S, et al. Notch pathway and Inteleukin-6 cooperate to support multiple myeloma cell proliferation[J]. Clin Lymphoma Myeloma Leuk, 2015, 15:e233-e234.
[3]Garavelli S, Colombo M, Thümmler K, et al.Notch signaling dysregulation promotes multiple myeloma-associated bone disease[J]. Clin Lymphoma Myeloma Leuk, 2015, 15:e233-e233.
[4]Saltarella I, Lamanuzzi A, Leone P, et al. Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression[J]. Clin Lymphoma Myeloma Leuk, 2015,15:e239-e240.
[5]Berenstein R, Nogai A, Waechter M, et al. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223[J]. Mol Carcinog,2015, 55(12): 1927-1939.
[6]Ding Y, Shen Y. Notch increased vitronection adhesion protects myeloma cells from drug induced apoptosis[J]. Biochem Biophys Res Commun, 2015, 467(4):717-722.
[7]徐又海, 汪兴洪. Shh、Gli1基因在多发性骨髓瘤中的表达及临床意义[J].中国临床药理学与治疗学, 2015, 20(3):309-313.
[8]Das DS, Das A, Ray A, et al. Blockade of deubiquitylating enzyme USP1 Inhibits DNA repair and triggers apoptosis in multiple myeloma cells [J]. Clin Cancer Res, 2017,23(15):4280-4289.
[9]Colombo M, Galletti S, Bulfamante G, et al.Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche[J]. Oncotarget,2016, 7(35):56013-56029.
[10]Franquimachin R, Wendlandt EB, Janz S, et al. Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction [J] ? Oncotarget, 2015, 6(38):40496-40506.
[11]Pisklakova A, Grigson E, Ozerova M, et al. Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment[J]. Cancer Biol Ther, 2016, 17(5): 477-485.
[12]宋今丹,章静波,陈誉华.医学细胞分子生物学[M].北京:人民卫生出版社,2003:454.
[13]Gomes CC,Drummond SN,Guimaraes AL,et al.P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma[J].J Oral Pathol Med,2008,37(3):151-156.
[14]郭益群, 陈世伦.多发性骨髓瘤骨髓基质细胞分泌IGF-1、VEGF和IL-6的动态变化[J]. 中华血液学, 2006, 27(4): 231-234.
[15]Acaz-Fonseca E, Sanchez-Gonzalez R, Astiz M, et al. Notch signaling is regulated by IGF-1 in astrocytes[C]// Biennial Meeting of the International-Society-For-Neurochemistry. 2015:102-102.
[16]赖静兰,刘玉明, 林春,等. 乙型肝炎相关慢加急性肝衰竭患者血清白细胞介素1受体拮抗剂与疾病严重程度的关系[J].临床肝胆病杂志, 2016, 32(5):890-893. |